Lateral Flow Assays market expected to reach $18.59 billion by 2032 with strong growth potential.

From GlobeNewswire: 2025-05-09 08:30:00

The Lateral Flow Assays Market was valued at USD 10.94 billion in 2023, projected to reach USD 18.59 billion by 2032, with a CAGR of 6.09%. Growing demand for quick diagnostic solutions in healthcare, food safety, and environmental testing is driving market growth. The U.S. dominates the North American market due to advanced healthcare infrastructure and increased demand for point-of-care testing.

Major players in the market include Abbott Laboratories, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, and Bio-Rad Laboratories. The Kits & Reagents segment leads the market with a 71.1% share, driven by extensive usage in rapid diagnosis applications. Clinical Testing holds a 79.2% market share, fueled by the need for fast and accurate diagnostic devices. Sandwich Assays dominate with a 42.3% market share, known for high sensitivity and accuracy in detecting analytes. Lateral Flow Immunoassays hold a 69.3% market share, widely used in rapid diagnostic testing across various industries. The Lateral Flow Assays market is booming post-pandemic, with a need for cost-saving diagnostic tools. The market is segmented by product, application, technique, therapy, and end-use. North America leads with 36.6% market share, while Asia Pacific is expected to see rapid growth due to a growing population and increased healthcare investments.

To learn more about the Lateral Flow Assays market analysis and outlook, connect with our team of analysts. The market is dominated by North America, but Asia Pacific is expected to show the fastest growth. The market is segmented by product, application, technique, therapy, and end-use, with a focus on technological advancements and innovation trends.

Stay informed about the latest trends and insights in the Lateral Flow Assays market by checking out related reports on the Point-of-Care Testing Market, Home Healthcare Devices Market, Veterinary Diagnostics Market, Multiplex Assays Market, and Clinical Diagnostics Market. SNS Insider is a leading market research and consulting agency providing clients with accurate market data and insights to make confident decisions in a changing environment.



Read more at GlobeNewswire: Lateral Flow Assays Market Projected to Reach USD 18.59